by Virtus | Feb 4, 2026 | Early-Stage Respiratory Drug Development
Early stage respiratory drug development focuses on evaluating therapeutic feasibility, biological activity, and translational relevance before compounds progress into clinical investigation. At this stage, preclinical respiratory studies are designed to generate...
by Virtus | Feb 4, 2026 | Respiratory Preclinical Research, Uncategorized
A respiratory preclinical CRO in the UK provides specialist research services to support early stage respiratory drug development, translational research, and preclinical efficacy testing. These organisations focus on delivering disease-relevant respiratory...
by Virtus | Feb 4, 2026 | Viral & Rhinovirus Models, Uncategorized
Influenza preclinical models are widely used in respiratory preclinical research to investigate viral pathogenesis, evaluate therapeutic efficacy, and support respiratory drug development programmes. Influenza virus infection is associated with acute respiratory...
by Virtus | Feb 4, 2026 | Viral & Rhinovirus Models, Uncategorized
RSV preclinical models are widely used in respiratory preclinical research to investigate viral pathogenesis, evaluate therapeutic efficacy, and support early stage respiratory drug development. Respiratory syncytial virus (RSV) is a significant cause of lower...
by Virtus | Jan 6, 2026 | In Vivo Respiratory Studies, In Vivo Respiratory Studies
In vivo respiratory studies are a cornerstone of respiratory preclinical research and are widely used within translational programmes to support early stage respiratory drug development in the UK. Biotech and pharmaceutical sponsors frequently rely on invivo...
